BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds
BillionToOne announced the publication of a real-world peer-reviewed study demonstrating that its tissue-free Northstar Response liquid biopsy assay tracks cancer treatment response as effectively or better than a commercially available tumor-informed assay, without needing tumor tissue sequencing. The study showed high concordance in measuring tum…